503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.77%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
8.93%
Cost growth less than half of CRWV's 19.16%. David Dodd would verify if cost advantage is structural.
-5.44%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
-4.70%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
-1.86%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
-16.17%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-20.38%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
46.97%
Other expenses growth above 1.5x CRWV's 19.33%. Michael Burry would check for concerning trends.
-13.45%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-3.31%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
-4.73%
Interest expense reduction while CRWV shows 1.19% growth. Joel Greenblatt would examine advantage.
-18.03%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-11.82%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
1.90%
EBITDA margin growth below 50% of CRWV's 7.69%. Michael Burry would check for structural issues.
-9.84%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-9.14%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-45.26%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-10.35%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-9.65%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-30.99%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-1.56%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-0.79%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-1.79%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-1.82%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
0.04%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.07%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.